Platinum

ATPase copper transporting alpha ; Homo sapiens







25 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35265524 Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer. 2022 1
2 34533854 FGF13 enhances resistance to platinum drugs by regulating hCTR1 and ATP7A via a microtubule-stabilizing effect. 2021 Nov 1
3 32006874 The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents. 2020 Mar 15 1
4 32570116 The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer. 2020 Sep 1
5 31540259 Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs. 2019 Sep 13 2
6 31934199 Expression of ATP7A in esophageal squamous cell carcinoma (ESCC) and its clinical significance. 2019 3
7 29394468 Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy. 2018 Mar 3
8 29970670 ATP7B rs9535826 is associated with gastrointestinal toxicity of platinum-based chemotherapy in nonsmall cell lung cancer patients. 2018 2
9 28164426 Mechanisms of charge transfer in human copper ATPases ATP7A and ATP7B. 2017 Apr 1
10 28737129 Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer. 2017 Oct 1
11 27014726 Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer. 2016 Jun 2
12 27877224 The role of copper transporter ATP7A in platinum-resistance of esophageal squamous cell cancer (ESCC). 2016 2
13 24038379 miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A). 2014 Jul 3
14 24983998 Platination of the copper transporter ATP7A involved in anticancer drug resistance. 2014 Aug 21 1
15 25070243 Cytotoxic effects of pyrrolidine dithiocarbamate in small-cell lung cancer cells, alone and in combination with cisplatin. 2014 Oct 1
16 25242165 Biochemical characterization of P-type copper ATPases. 2014 Oct 15 1
17 23751120 Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification. 2013 Aug 15 1
18 22304828 Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). 2012 Feb 3 5
19 22710939 Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A. 2012 Sep 2
20 22966390 Association of ATP7A expression and in vitro sensitivity to cisplatin in non-small cell lung cancer. 2010 Sep 2
21 19296535 Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy. 2009 Jun 15 1
22 19509135 Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin. 2009 Jul 1 1
23 20045993 Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients. 2009 1
24 15213293 Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. 2004 Jul 1
25 14676106 Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. 2003 Dec 1 1